| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 21, 2026 | ±1.8% | -7.0% | under-priced |
| October 21, 2025 | ±2.3% | -0.4% | over-priced |
| July 22, 2025 | ±1.7% | +9.4% | under-priced |
| April 22, 2025 | ±2.4% | -12.7% | under-priced |
| October 24, 2024 | ±1.8% | +1.4% | over-priced |
| July 25, 2024 | ±1.6% | +6.4% | under-priced |
| April 25, 2024 | ±1.7% | +2.8% | under-priced |
| October 26, 2023 | ±1.6% | -1.1% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $6.14 | $9.9B | $875M |
| Q4 FY2025 | $9.96 | $11.7B | $1.4B |
| Q3 FY2025 | $7.67 | $10.4B | $1.1B |
| Q2 FY2025 | $8.15 | $10.4B | $1.2B |
Northrop Grumman Corp. (NOC) reports in 83 days, with the next report estimated for September 4, 2026. Across the last 8 reports, options priced an average ±1.9% earnings move while the stock actually moved 5.2% on average — the market has been roughly fair on NOC's earnings risk. Fundamentals into the print: EPS up 84.9% year-over-year, revenue up 4.4%. QuantLogix's live 5-factor engine currently reads NOC as a neutral at 47/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →